Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 51436-99-8 | MDL No. : | MFCD00013551 |
Formula : | C7H6BrF | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YZFVUQSAJMLFOZ-UHFFFAOYSA-N |
M.W : | 189.03 | Pubchem ID : | 171040 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 39.07 |
TPSA : | 0.0 Ų |
GI absorption : | Low |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.27 cm/s |
Log Po/w (iLOGP) : | 2.33 |
Log Po/w (XLOGP3) : | 3.08 |
Log Po/w (WLOGP) : | 3.32 |
Log Po/w (MLOGP) : | 3.79 |
Log Po/w (SILICOS-IT) : | 3.4 |
Consensus Log Po/w : | 3.19 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.45 |
Solubility : | 0.0677 mg/ml ; 0.000358 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.75 |
Solubility : | 0.338 mg/ml ; 0.00179 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.92 |
Solubility : | 0.0228 mg/ml ; 0.000121 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.14 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H227-H315-H319-H335-H412 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
89% | With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane at 100℃; for 13 h; | 4-bromo-1-(bromomethyl)-2-fluorobenzene NBS (1.07 g, 6.05 mmol) and AIBN (83 mg, 0.50 mmol) were dissolved in CCl4 (10 mL), and 1-bromo-2-fluoro-4-methylbenzene (1 g, 5.04 mmol) was added, followed by heating at 100° C. under reflux for 13 hours. When the reaction was completed, the reaction mixture was cooled at room temperature, and the generated solid was filtered off, followed by extraction with CCl4 and water two times or more. The organic layer was treated with sodium sulfate to remove extra water, followed by concentration under reduced pressure, to give 4-bromo-1-(bromomethyl)-2-fluorobenzene (1.2 g, 4.47 mmol) with a yield of 89percent. 1H-NMR (300 MHz, CDCl3) δ 7.51-7.41 (m, 1H), 7.09 (d, J=9.0 Hz, 1H), 6.99 (d, J=8.2 Hz, 1H), 4.34 (s, 2H) |
89% | With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane at 100℃; for 13 h; | [0268] 1-Bromo-2-fluoro-4-methylbenzene (1 g, 5.04 mmol) was added to the solution after dissolving NBS (1.07 g, 6.05 mmol) and AIBN (83 mg, 0.50 mmol) in CCl4 And the mixture was refluxed at 100 deg C for 13 hours. After the reaction was completed, the reaction mixture was cooled at room temperature, and the resulting solid was filtered. After the extraction with CCl4 and water more than 2 times, the organic layer was dried over anhydrous to remove excess water, then concentrated under reduced pressure 4-Bromo-1- (bromomethyl) -2-fluorobenzene (1.2 g, 4.47 mmol) was obtained in 89percent yield |
53% | With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) In tetrachloromethane for 4 h; Reflux; Inert atmosphere | A mixture of 4-bromo-2-fiuoro-l-methylbenzene (available from Aldrich; 2.0 g, 10.58 mmol), N-bromosuccinimide (1.88 g, 10.58 mmol) and AIBN (87 mg, 0.53 mmol) in CCI4 (30 mL) was heated at reflux under nitrogen for 4 h. The reaction mixture was cooled to room temperature, 5percent aqueous Na2S2C"3 solution was added and the mixture was concentrated. Water (10 mL) was added and the mixture was extracted with EtOAc (3 x 50 mL). The combined organic phases were dried (Na2S04), filtered, and evaporated. The residue was purified by chromatography (silica gel, hexane) to give 4-bromo-l-bromomethyl-2-fiuoro-benzene (1.5 g, 53percent) as a colorless liquid. |
[ 51437-00-4 ]
4-Bromo-1-fluoro-2-methylbenzene
Similarity: 0.97
[ 99725-44-7 ]
5-Bromo-2-fluoro-1,3-dimethylbenzene
Similarity: 0.93
[ 76283-09-5 ]
4-Bromo-1-(bromomethyl)-2-fluorobenzene
Similarity: 0.91
[ 627463-25-6 ]
4-Bromo-2-ethyl-1-fluorobenzene
Similarity: 0.90
[ 51437-00-4 ]
4-Bromo-1-fluoro-2-methylbenzene
Similarity: 0.97
[ 99725-44-7 ]
5-Bromo-2-fluoro-1,3-dimethylbenzene
Similarity: 0.93
[ 76283-09-5 ]
4-Bromo-1-(bromomethyl)-2-fluorobenzene
Similarity: 0.91
[ 627463-25-6 ]
4-Bromo-2-ethyl-1-fluorobenzene
Similarity: 0.90
[ 51437-00-4 ]
4-Bromo-1-fluoro-2-methylbenzene
Similarity: 0.97
[ 99725-44-7 ]
5-Bromo-2-fluoro-1,3-dimethylbenzene
Similarity: 0.93
[ 76283-09-5 ]
4-Bromo-1-(bromomethyl)-2-fluorobenzene
Similarity: 0.91
[ 627463-25-6 ]
4-Bromo-2-ethyl-1-fluorobenzene
Similarity: 0.90